9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      P2X7 Receptor at the Crossroads of T Cell Fate

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The P2X7 receptor is a ligand-gated, cation-selective channel whose main physiological ligand is ATP. P2X7 receptor activation may also be triggered by ARTC2.2-dependent ADP ribosylation in the presence of extracellular NAD. Upon activation, this receptor induces several responses, including the influx of calcium and sodium ions, phosphatidylserine externalization, the formation of a non-selective membrane pore, and ultimately cell death. P2X7 receptor activation depends on the availability of extracellular nucleotides, whose concentrations are regulated by the action of extracellular nucleotidases such as CD39 and CD38. The P2X7 receptor has been extensively studied in the context of the immune response, and it has been reported to be involved in inflammasome activation, cytokine production, and the migration of different innate immune cells in response to ATP. In adaptive immune responses, the P2X7 receptor has been linked to T cell activation, differentiation, and apoptosis induction. In this review, we will discuss the evidence of the role of the P2X7 receptor on T cell differentiation and in the control of T cell responses in inflammatory conditions.

          Related collections

          Most cited references121

          • Record: found
          • Abstract: found
          • Article: not found

          Memory T cell subsets, migration patterns, and tissue residence.

          Tissues such as the skin and mucosae are frequently exposed to microbial pathogens. Infectious agents must be quickly and efficiently controlled by our immune system, but the low frequency of naive T cells specific for any one pathogen means dependence on primary responses initiated in draining lymph nodes, often allowing time for serious infection to develop. These responses imprint effectors with the capacity to home to infected tissues; this process, combined with inflammatory signals, ensures the effective targeting of primary immunity. Upon vaccination or previous pathogen exposure, increased pathogen-specific T cell numbers together with altered migratory patterns of memory T cells can greatly improve immune efficacy, ensuring infections are prevented or at least remain subclinical. Until recently, memory T cell populations were considered to comprise central memory T cells (TCM), which are restricted to the secondary lymphoid tissues and blood, and effector memory T cells (TEM), which broadly migrate between peripheral tissues, the blood, and the spleen. Here we review evidence for these two memory populations, highlight a relatively new player, the tissue-resident memory T cell (TRM), and emphasize the potential differences between the migratory patterns of CD4(+) and CD8(+) T cells. This new understanding raises important considerations for vaccine design and for the measurement of immune parameters critical to the control of infectious disease, autoimmunity, and cancer.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Purinergic regulation of the immune system.

            Cellular stress or apoptosis triggers the release of ATP, ADP and other nucleotides into the extracellular space. Extracellular nucleotides function as autocrine and paracrine signalling molecules by activating cell-surface P2 purinergic receptors that elicit pro-inflammatory immune responses. Over time, extracellular nucleotides are metabolized to adenosine, leading to reduced P2 signalling and increased signalling through anti-inflammatory adenosine (P1 purinergic) receptors. Here, we review how local purinergic signalling changes over time during tissue responses to injury or disease, and we discuss the potential of targeting purinergic signalling pathways for the immunotherapeutic treatment of ischaemia, organ transplantation, autoimmunity or cancer.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Immune cell regulation by autocrine purinergic signalling.

              Stimulation of almost all mammalian cell types leads to the release of cellular ATP and autocrine feedback through a diverse array of purinergic receptors. Depending on the types of purinergic receptors that are involved, autocrine signalling can promote or inhibit cell activation and fine-tune functional responses. Recent work has shown that autocrine signalling is an important checkpoint in immune cell activation and allows immune cells to adjust their functional responses based on the extracellular cues provided by their environment. This Review focuses on the roles of autocrine purinergic signalling in the regulation of both innate and adaptive immune responses and discusses the potential of targeting purinergic receptors for treating immune-mediated disease.
                Bookmark

                Author and article information

                Journal
                Int J Mol Sci
                Int J Mol Sci
                ijms
                International Journal of Molecular Sciences
                MDPI
                1422-0067
                13 July 2020
                July 2020
                : 21
                : 14
                : 4937
                Affiliations
                [1 ]Departamento de Biología, Facultad de Ciencias, Universidad de Chile, Santiago 7800003, Chile; elizabeth.ecry@ 123456gmail.com (E.R.-Y.); brian.parrat@ 123456gmail.com (B.P.-T.); pedro.bcatalan@ 123456gmail.com (P.B.); mariana.rosemblatt.b@ 123456gmail.com (M.V.R.); juan.saavedra.a24@ 123456gmail.com (J.S.-A.); mrosemblatt@ 123456cienciavida.org (M.R.)
                [2 ]Departamento de Biología, Facultad de Química y Biología, Universidad de Santiago de Chile, Santiago 9160000, Chile; carlos.barrera@ 123456usach.cl
                [3 ]Facultad de Medicina y Ciencia, Universidad San Sebastián, Santiago 7510157, Chile
                [4 ]Fundación Ciencia & Vida, Santiago 7780272, Chile
                [5 ]Centro de Biotecnología Acuícola, Universidad de Santiago de Chile, Santiago 9160000, Chile
                Author notes
                Author information
                https://orcid.org/0000-0001-6160-9563
                https://orcid.org/0000-0003-2268-4733
                https://orcid.org/0000-0002-2329-6284
                Article
                ijms-21-04937
                10.3390/ijms21144937
                7404255
                32668623
                49950691-362d-4e59-9cc6-60faf6014270
                © 2020 by the authors.

                Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( http://creativecommons.org/licenses/by/4.0/).

                History
                : 04 June 2020
                : 07 July 2020
                Categories
                Review

                Molecular biology
                p2x7 receptor,ectonucleotidases,t cell
                Molecular biology
                p2x7 receptor, ectonucleotidases, t cell

                Comments

                Comment on this article